The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rowarolan Cutaneous Powder

Rowa Pharmaceuticals LimitedPA0074/046/001

Main Information

Trade NameRowarolan Cutaneous Powder
Active SubstancesCalcium carbonate
Dosage FormCutaneous powder
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/046/001

Group Information

ATC Code


License statusAuthorised
Licence Issued05/02/1999
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back